Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125065752 | 12506575 | 2 | F | 20160601 | 20160815 | 20160628 | 20160819 | EXP | PL-TAKEDA-2016MPI005874 | TAKEDA | 69.00 | YR | F | Y | 90.00000 | KG | 20160819 | MD | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125065752 | 12506575 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 2.7 MG, 2/WEEK | 4371089 | 21602 | 2.7 | MG | INJECTION | BIW | |||||
| 125065752 | 12506575 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 120 MG, UNK | 4370217 | 0 | 120 | MG | |||||||
| 125065752 | 12506575 | 3 | SS | MELPHALAN | MELPHALAN | 1 | Oral | 18 MG, UNK | M13065;M13069 | 0 | 18 | MG | |||||||
| 125065752 | 12506575 | 4 | C | PIRAMIL | RAMIPRIL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 125065752 | 12506575 | 5 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 1.5 MG, QD | 0 | 1.5 | MG | COATED TABLET | QD | ||||||
| 125065752 | 12506575 | 6 | C | METOCLOPRAMIDUM | 2 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
| 125065752 | 12506575 | 7 | C | HELICID /00661201/ | 2 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | QD | |||||||
| 125065752 | 12506575 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 20 MG, QD | 0 | 20 | MG | COATED TABLET | QD | ||||||
| 125065752 | 12506575 | 9 | C | HEVIRAN /00587301/ | 2 | Oral | 0 | 200 | MG | TABLET | BID | ||||||||
| 125065752 | 12506575 | 10 | C | NACL | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 500 ML, QD | 1000 | ML | 0 | 500 | ML | INJECTION | QD | ||||
| 125065752 | 12506575 | 11 | C | ISOLYTE /07307001/ | 2 | Intravenous (not otherwise specified) | 1000 ML, QD | 2000 | ML | 0 | 1000 | ML | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125065752 | 12506575 | 1 | Plasma cell myeloma |
| 125065752 | 12506575 | 2 | Plasma cell myeloma |
| 125065752 | 12506575 | 3 | Plasma cell myeloma |
| 125065752 | 12506575 | 4 | Hypertension |
| 125065752 | 12506575 | 5 | Hypertension |
| 125065752 | 12506575 | 6 | Reflux gastritis |
| 125065752 | 12506575 | 7 | Reflux gastritis |
| 125065752 | 12506575 | 8 | Hypercholesterolaemia |
| 125065752 | 12506575 | 9 | Infection prophylaxis |
| 125065752 | 12506575 | 10 | Dehydration |
| 125065752 | 12506575 | 11 | Dehydration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125065752 | 12506575 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125065752 | 12506575 | Adjustment disorder with depressed mood | |
| 125065752 | 12506575 | Anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125065752 | 12506575 | 1 | 20160524 | 0 | ||
| 125065752 | 12506575 | 2 | 20160524 | 0 | ||
| 125065752 | 12506575 | 3 | 20160524 | 0 | ||
| 125065752 | 12506575 | 4 | 2011 | 0 | ||
| 125065752 | 12506575 | 5 | 2011 | 0 | ||
| 125065752 | 12506575 | 6 | 2011 | 0 | ||
| 125065752 | 12506575 | 7 | 2011 | 0 | ||
| 125065752 | 12506575 | 8 | 2011 | 0 | ||
| 125065752 | 12506575 | 9 | 20160524 | 0 | ||
| 125065752 | 12506575 | 10 | 20160531 | 20160601 | 0 | |
| 125065752 | 12506575 | 11 | 20160531 | 20160601 | 0 |